Cellectis S.A. (CLLS) Operating cash flow 2016–2025
Cellectis S.A. (CLLS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$39.4MFY2025 · since FY2016: -$32.7M → -$39.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.4M | -271.4% |
| FY2024 | $23.0M | +192.9% |
| FY2023 | -$24.7M | +71.7% |
| FY2022 | -$87.4M | +16.4% |
| FY2021 | -$104.6M | -30.3% |
| FY2020 | -$80.3M | -16.1% |
| FY2019 | -$69.1M | -1.5% |
| FY2018 | -$68.1M | -30.2% |
| FY2017 | -$52.3M | -60.0% |
| FY2016 | -$32.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLLS financial trends
CLLS RevenueCLLS Net incomeCLLS Net marginCLLS Gross profitCLLS Gross marginCLLS Operating incomeCLLS Operating marginCLLS Free cash flowCLLS Capital expendituresCLLS Return on equityCLLS Stock buybacksCLLS Dividends paidCLLS Total assetsCLLS Total liabilitiesCLLS Shareholders’ equityCLLS overview →